Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Other medication classes used in diabetes

Journal articles and book chapters

22-05-2018 | Cardiovascular disorders | Article

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes

Matsutani D et al. Cardiovasc Diabetol 2018; 17: 73. doi: 10.1186/s12933-018-0717-9

19-05-2018 | Risk factors | Review | Article

Prioritising risk factors for type 2 diabetes: Causal inference through genetic approaches

Wittemans LBL, Lotta LA, Langenberg C. Curr Diab Rep 2018; 18: 40. doi: 10.1007/s11892-018-1009-1

19-05-2018 | Liraglutide (T2DM) | Article

Retrospective analysis of an insulin-to-liraglutide switch in patients with type 2 diabetes mellitus

Introduction: Insulin and the GLP-1 receptor agonist liraglutide are both effective in reaching glycemic targets. The efficacy of an insulin-to-liraglutide switch in an obese population with concurrent use of sulfonylurea and metformin is unknown. We assessed the efficacy and determinants of success of an insulin-to-liraglutide switch in these patients.

15-05-2018 | Diet | Article

Glycemic impact of non-nutritive sweeteners: A systematic review and meta-analysis of randomized controlled trials

Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

15-05-2018 | Type 2 diabetes | Article

Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: A matched case–control analysis

Owusu Adjah ES et al. Cardiovasc Diabetol 2018; 17: 70. doi: 10.1186/s12933-018-0712-1

14-05-2018 | Insulin glargine | Article

Characteristics of insulin-naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: A meta-analysis of individual participant data from 3 randomized clinical trials

Cummings MH et al. Clin Diabetes Endocrinol 2018; 4: 10. doi: 10.1186/s40842-018-0059-2

11-05-2018 | Artificial pancreas systems | Article

Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors

Castle JR et al. Diabetes Care 2018. doi: 10.2337/dc18-0228

08-05-2018 | Cardiovascular disorders | Article

Sex-specific relevance of diabetes to occlusive vascular and other mortality: A collaborative meta-analysis of individual data from 980,793 adults from 68 prospective studies

Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Lancet Diabetes Endocrinol 2018; Advance online publication. doi: 10.1016/S2213-8587(18)30079-2

25-04-2018 | Lipid-lowering medications | Article

Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: Systemic assessment of pharmacological and nutritional factors

Gant CM et al. Nutr Diabetes 2018; 8: 24. doi: 10.1038/s41387-018-0028-y

18-04-2018 | Artificial pancreas systems | Article

Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis

Bekiari E et al. BMJ 2018; 361: k1310. doi: 10.1136/bmj.k1310 

16-04-2018 | Type 1 diabetes | Review | Article

The potential role of SGLT2 inhibitors in the treatment of type 1 diabetes mellitus

Fattah H, Vallon, V. Drugs 2018; 78: 717–726. doi: 10.1007/s40265-018-0901-y

06-04-2018 | Statins | Article

Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: Report of a randomized study

Itho H et al. Diabetes Care 2018; Advance online publication. doi: 10.2337/dc17-2224

06-02-2018 | Osteoporosis | Review | Article

Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: A systematic review

Anagnostis P et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1548-x

05-02-2018 | Cardiovascular disorders | Review | Article

Type 2 diabetes and thiazide diuretics

Scheen AJ. Curr Diab Rep 2018; 18: 6. doi: 10.1007/s11892-018-0976-6

28-01-2018 | Cardiovascular disorders | Review | Article

Blood pressure targets in type 2 diabetes. Evidence against or in favor of an aggressive approach

Mancia G, Grassi G. Diabetologia 2018; 61: 517–525. doi: 10.1007/s00125-017-4537-3

05-01-2018 | Cardiovascular outcomes | Review | Article

Pharmacological prevention of cardiovascular outcomes in diabetes mellitus: Established and emerging agents

Saxon DR, Rasouli N, Eckel RH. Drugs 2018; 78: 203–214. doi: 10.1007/s40265-017-0857-3

19-12-2017 | Cardiovascular disorders | Review | Article

New treatment options for lipid-lowering therapy in subjects with type 2 diabetes

Scicali R et al. Acta Diabetol 2017; 55: 209–218. doi: 10.1007/s00592-017-1089-4

19-10-2017 | Retinopathy | Review | Article

Diabetic retinopathy: Research to clinical practice

Shah AR, Gardner TW. Clin Diabetes Endocrinol 2017; 3: 9. doi: 10.1186/s40842-017-0047-y

17-10-2017 | Nephropathy | Review | Article

B cells in type 1 diabetes mellitus and diabetic kidney disease

Nat Rev Nephrol 2017; 13: 712–720. doi: 10.1038/nrneph.2017.138

13-10-2017 | Obesity | Review | Article

Current pharmacotherapy for obesity

​​​​​​​Nat Rev Endocrinol 2017; 14: 12–24. doi: 10.1038/nrendo.2017.122

Next Previous
Image Credits